LifeMD, Inc.
For the period ended Mar 31, 2026. Filed May 6, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 6, 2026
LFMD$2.10-11.6%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Incorporated by Reference | ||||
|---|---|---|---|---|
| Exhibit Number | Exhibit Description | Form | Exhibit | Filing Date/Period End Date |
| 10.1# | Resignation & Transition Services Agreement, dated March 16, 2026, between LifeMD, Inc. and Marc Benathen. | 8-K | 10.1 | 3/16/2026 |
| 10.2# | Employment Agreement, dated March 16, 2026 between LifeMD, Inc. and Atul Kavthekar | 8-K | 10.2 | 3/16/2026 |
| 10.3*# | First Renewed Director Agreement, dated October 2, 2025 by and between LifeMD, Inc. and Calum MacRae | |||
| 10.4*# | Third Amendment to the Director Agreement, dated October 6, 2025, between Dr. Joan LaRovere and LifeMD, Inc. | |||
| 10.5 | Credit Agreement between LifeMD, Inc., and Citizens Bank, N.A., dated January 2, 2026 | 8-K | 10.1 | 1/6/2026 |
| 10.6 | Guarantee Agreement among LifeMD, Inc., each of the Subsidiary Guarantors party thereto, and Citizens Bank, N.A., dated January 2, 2026 | 8-K | 10.2 | 1/6/2026 |
| 10.7 | Pledge and Security Agreement among LifeMD, Inc., each of the Guarantors party thereto, and Citizens Bank, N.A., dated January 2, 2026 | 8-K | 10.3 | 1/6/2026 |
| 10.8 | Revolving Loan Note issued by LifeMD, Inc. to Citizens Bank, N.A., dated January 2, 2026 | 8-K | 10.4 | 1/6/2026 |
| 31.1* | Rule 13a-14(a) / 15d-14(a) Certification of Chief Executive Officer. | |||
| 31.2* | Rule 13a-14(a) / 15d-14(a) Certification of Chief Financial Officer. | |||
| 32.1** | Section 1350 Certification of Chief Executive Officer. | |||
| 32.2** | Section 1350 Certification of Chief Financial Officer. | |||
| 101.INS* | Inline XBRL Instance Document | |||
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document | |||
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document | |||
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document | |||
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document | |||
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document | |||
| 104* | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101.INS) | |||
# Indicates management contract or compensatory plan, contract or arrangement.
** Filed herewith.*
**Furnished herewith
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.